Companies Investors People

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Fosun Pharma›

Library

Fosun Pharma

Fosun Pharma is a brand-new company record, and its full research profile isn't ready yet.

Browse other records

Library

fosunpharma.comCrawled Oct 25, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

Healthcare services/business/service.html
Fuxing Health fulfills its mission of 'Making families healthier and lives more beautiful' by leveraging strengths in medicine, pharmaceuticals, insurance, health consumption, and smart technology to build a medical-grade, full-scenario, one-stop health ecosystem.
Medical diagnostics: diagnostic products and test kits/business/diagnosis.html
Fuxing Diagnostics, a subsidiary of Fuxing Pharmaceutical, was founded in 1989. It develops and commercializes innovative diagnostic technologies, focusing on in vitro diagnostics to become a global leader in medical diagnostic solutions.
mRNA vaccines: covid-19 vaccine/business/vaccine.html
The mRNA covid-19 vaccine (BNT162b2), developed jointly by Fuxing Pharmaceutical and BioNTech, was included in the Hong Kong and Macau government vaccination programs in March 2021 and launched in Taiwan in September 2021, supporting immunity barriers in these regions.
Our business/business

Press

6 pages

Company updates/news/dynamic.html
Fosun Pharma to disclose FS-1502 pharmacokinetics at ASCPT 2023/content/details168_10158.html
Media contacts/news/liaison.html
Media coverage/news/media.html

Careers & Hiring

6 pages

Career growth/careers
Employee life/careers/life.html
Fuxing Pharmaceutical, guided by the brand philosophy of 'Continuous Innovation, Enjoying Healthy Life,' aims to become a leading enterprise in the global mainstream healthcare market.
Focus on talent/esg/talent.html
Sustainability/en/occupation

Team

2 pages

Board and leadership/about/team.html
Executives/about/team_2.html
Fuxing Pharmaceutical refines its corporate governance structure and optimizes internal management, establishing a board of directors, supervisory board, and executive team with effective decision-making rules and operational processes.

About

6 pages

About Fosun Pharma/about
Brand culture/about/culture.html
Company awards/about/honor.html
ESG/esg

Contact

3 pages

Contact us/contact
Fuxing Pharmaceutical’s address is 1289 Yishan Road, Shanghai (Fuxing Science Park A Building), with contact number +86-21-33987000.
Customer complaints/customer/complaints.html
Fuxing Pharmaceutical accepts customer complaints and feedback through this page, processing them according to regulations.
Investor contacts/investor/liaison.html

Homepage

1 page

Home/
Founded in 1994, Fuxing Pharmaceutical is a China-based, innovation-driven global healthcare group. Its core operations include pharmaceuticals, medical devices, diagnostics, and healthcare services, with additional reach in pharmaceutical distribution through its stake in China National Pharmaceutical Group.

Privacy

1 page

Privacy protection/other/privacy.html

Terms & Conditions

1 page

Legal terms/other/law.html